These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 37466681)

  • 1. Chemical tagging mass spectrometry: an approach for single-cell omics.
    Lu H; Zhang H; Li L
    Anal Bioanal Chem; 2023 Nov; 415(28):6901-6913. PubMed ID: 37466681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-cell mass spectrometry.
    Tajik M; Baharfar M; Donald WA
    Trends Biotechnol; 2022 Nov; 40(11):1374-1392. PubMed ID: 35562238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatially Resolved Mass Spectrometry at the Single Cell: Recent Innovations in Proteomics and Metabolomics.
    Taylor MJ; Lukowski JK; Anderton CR
    J Am Soc Mass Spectrom; 2021 Apr; 32(4):872-894. PubMed ID: 33656885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stepwise solid phase extraction integrated with chemical derivatization for all-in-one injection LC-MS/MS analysis of metabolome and lipidome.
    Chen J; Zhang P; Qin S; Tan B; Li S; Tang S; Liao C; Zhang Y; Zhang Z; Xu F
    Anal Chim Acta; 2023 Feb; 1241():340807. PubMed ID: 36657877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards high throughput and high information coverage: advanced single-cell mass spectrometric techniques.
    Xu S; Yang C; Yan X; Liu H
    Anal Bioanal Chem; 2022 Jan; 414(1):219-233. PubMed ID: 34435209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical derivatization strategy for mass spectrometry-based lipidomics.
    Xia F; Wan JB
    Mass Spectrom Rev; 2023 Jan; 42(1):432-452. PubMed ID: 34486155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recent advances in chemical derivatization-based chromatography-mass spectrometry methods for analysis of aldehyde biomarkers].
    Zhu S; Zhao XE; Liu H
    Se Pu; 2021 Aug; 39(8):845-854. PubMed ID: 34212585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New mass spectrometry technologies contributing towards comprehensive and high throughput omics analyses of single cells.
    Couvillion SP; Zhu Y; Nagy G; Adkins JN; Ansong C; Renslow RS; Piehowski PD; Ibrahim YM; Kelly RT; Metz TO
    Analyst; 2019 Jan; 144(3):794-807. PubMed ID: 30507980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass Spectrometry Techniques in Emerging Pathogens Studies: COVID-19 Perspectives.
    Mahmud I; Garrett TJ
    J Am Soc Mass Spectrom; 2020 Oct; 31(10):2013-2024. PubMed ID: 32880453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 'ForensOMICS' approach for postmortem interval estimation from human bone by integrating metabolomics, lipidomics, and proteomics.
    Bonicelli A; Mickleburgh HL; Chighine A; Locci E; Wescott DJ; Procopio N
    Elife; 2022 Dec; 11():. PubMed ID: 36583441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in ionisation techniques for mass spectrometry-based omics research.
    Challen B; Cramer R
    Proteomics; 2022 Aug; 22(15-16):e2100394. PubMed ID: 35709387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cell metabolomics by mass spectrometry: ready for primetime?
    Zhang C; Le Dévédec SE; Ali A; Hankemeier T
    Curr Opin Biotechnol; 2023 Aug; 82():102963. PubMed ID: 37356380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Power of LC-MS Based Multiomics: Exploring Adipogenic Differentiation of Human Mesenchymal Stem/Stromal Cells.
    Rampler E; Egger D; Schoeny H; Rusz M; Pacheco MP; Marino G; Kasper C; Naegele T; Koellensperger G
    Molecules; 2019 Oct; 24(19):. PubMed ID: 31597247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding Metabolomics in Biomedical Research.
    Kim SJ; Kim SH; Kim JH; Hwang S; Yoo HJ
    Endocrinol Metab (Seoul); 2016 Mar; 31(1):7-16. PubMed ID: 26676338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomics, lipidomics and proteomics profiling of myoblasts infected with Trypanosoma cruzi after treatment with different drugs against Chagas disease.
    Hennig K; Abi-Ghanem J; Bunescu A; Meniche X; Biliaut E; Ouattara AD; Lewis MD; Kelly JM; Braillard S; Courtemanche G; Chatelain E; Béquet F
    Metabolomics; 2019 Aug; 15(9):117. PubMed ID: 31440849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological mass spectrometry enables spatiotemporal 'omics: From tissues to cells to organelles.
    Pade LR; Stepler KE; Portero EP; DeLaney K; Nemes P
    Mass Spectrom Rev; 2024; 43(1):106-138. PubMed ID: 36647247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical Derivatization and Ultrahigh Resolution and Accurate Mass Spectrometry Strategies for "Shotgun" Lipidome Analysis.
    Ryan E; Reid GE
    Acc Chem Res; 2016 Sep; 49(9):1596-604. PubMed ID: 27575732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ion mobility mass spectrometry in the omics era: Challenges and opportunities for metabolomics and lipidomics.
    Paglia G; Smith AJ; Astarita G
    Mass Spectrom Rev; 2022 Sep; 41(5):722-765. PubMed ID: 33522625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the future of "omics": lipidomics.
    Griffiths WJ; Ogundare M; Williams CM; Wang Y
    J Inherit Metab Dis; 2011 Jun; 34(3):583-92. PubMed ID: 21318352
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.